These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11091987)

  • 1. Injectable contraception. New and existing options.
    Kaunitz AM
    Obstet Gynecol Clin North Am; 2000 Dec; 27(4):741-80. PubMed ID: 11091987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
    Shulman LP; Oleen-Burkey M; Willke RJ
    Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group.
    Kaunitz AM; Garceau RJ; Cromie MA
    Contraception; 1999 Oct; 60(4):179-87. PubMed ID: 10640164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
    Rahimy MH; Ryan KK
    Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women.
    Rahimy MH; Ryan KK; Hopkins NK
    Contraception; 1999 Oct; 60(4):209-14. PubMed ID: 10640167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
    Rahimy MH; Cromie MA; Hopkins NK; Tong DM
    Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraception 2000: lunelle, an injectable combination contraceptive option.
    Shulman LP
    J Womens Health Gend Based Med; 2000 Sep; 9(7):725-9. PubMed ID: 11025864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland].
    Lech MM
    Wiad Lek; 2003; 56(7-8):362-8. PubMed ID: 14969166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): a contraceptive method for women in the US and worldwide.
    Kaunitz AM; Mishell DR
    Contraception; 1999 Oct; 60(4):177-8. PubMed ID: 10640163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent use of the monthly contraceptive injection.
    Tuchman LK; Huppert JS; Huang B; Slap GB
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):255-60. PubMed ID: 16171729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination injectable contraceptives for contraception.
    Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
    Cochrane Database Syst Rev; 2013; 3():CD004568. PubMed ID: 23641480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem.
    Bahamondes L; Lavín P; Ojeda G; Petta C; Diaz J; Maradiegue E; Monteiro I
    Contraception; 1997 May; 55(5):307-10. PubMed ID: 9220228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination injectable contraceptives for contraception.
    Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD004568. PubMed ID: 18843662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current options for injectable contraception in the United States.
    Kaunitz AM
    Semin Reprod Med; 2001 Dec; 19(4):331-7. PubMed ID: 11727175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical contraindications and issues for consideration in the use of once-a-month injectable contraceptives.
    Dorflinger LJ
    Contraception; 1994 May; 49(5):455-68. PubMed ID: 8045132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.